Jump to content

Zurich Insurance Group full year 2025 results investor and media presentation/Other important information: Difference between revisions

Content deleted Content added
No edit summary
Tag: Reverted
No edit summary
Tag: Reverted
Line 308: Line 308:


<div class="sticky-table-wrapper">
<div class="sticky-table-wrapper">
{| class="wikitable sticky-first-column" style="text-align:right;width:100%"
{| class="wikitable sticky-first-column" style="text-align:right; width:100%;"
|+ Zurich Insurance Group — L-f-l Growth Calculation by Segment (USDm), FY25 vs FY24
|+ Zurich Insurance Group — L-f-l Growth Calculation by Segment (USDm), FY25 vs FY24
! style="text-align:left" | Business
! style="text-align:left; width:11em;" | Business
! style="text-align:left" | KPI
! style="text-align:left; width:auto;" | Unit
! style="text-align:right;width:6em" | FY24 Rep.
! style="text-align:left; width:7em;" | KPI
! style="text-align:right;width:6em" | FY24 M&A/Other Adj.
! style="text-align:right; width:6em; white-space:normal;" | FY24 Rep.
! style="text-align:right;width:6em" | FY24 Adj.
! style="text-align:right; width:6em; white-space:normal;" | FY24 M&A/Other Adj.
! style="text-align:right;width:6em" | FY25 Rep.
! style="text-align:right; width:6em; white-space:normal;" | FY24 Adj.
! style="text-align:right;width:6em" | FY25 FX
! style="text-align:right; width:6em; white-space:normal;" | FY25 Rep.
! style="text-align:right;width:6em" | FY25 M&A/Other
! style="text-align:right; width:6em; white-space:normal;" | FY25 FX
! style="text-align:right;width:6em" | FY25 Adj.
! style="text-align:right; width:6em; white-space:normal;" | FY25 M&A/Other
! style="text-align:right;width:6em" | L-f-l (%)
! style="text-align:right; width:6em; white-space:normal;" | FY25 Adj.
! style="text-align:right; width:6em; white-space:normal;" | L-f-l (%)
|-
|-
| style="text-align:left" | P&C
| style="text-align:left" | P&C
| style="text-align:left" | USDm
| style="text-align:left" | GWP
| style="text-align:left" | GWP
| 46,624
| 46,624
Line 333: Line 335:
|-
|-
| style="text-align:left" | P&C
| style="text-align:left" | P&C
| style="text-align:left" | USDm
| style="text-align:left" | Ins. revenue
| style="text-align:left" | Ins. revenue
| 44,792
| 44,792
Line 344: Line 347:
|-
|-
| style="text-align:left" | Life
| style="text-align:left" | Life
| style="text-align:left" | USDm
| style="text-align:left" | GWP
| style="text-align:left" | GWP
| 33,061
| 33,061
Line 355: Line 359:
|-
|-
| style="text-align:left" | Life – long term
| style="text-align:left" | Life – long term
| style="text-align:left" | USDm
| style="text-align:left" | PVNBP
| style="text-align:left" | PVNBP
| 16,891
| 16,891
Line 366: Line 371:
|-
|-
| style="text-align:left" | Life – long term
| style="text-align:left" | Life – long term
| style="text-align:left" | USDm
| style="text-align:left" | NB CSM
| style="text-align:left" | NB CSM
| 1,094
| 1,094
Line 377: Line 383:
|-
|-
| style="text-align:left" | Life – short term
| style="text-align:left" | Life – short term
| style="text-align:left" | USDm
| style="text-align:left" | Ins. revenue
| style="text-align:left" | Ins. revenue
| 2,804
| 2,804
Line 388: Line 395:
|-
|-
| style="text-align:left" | Life – inv. contracts
| style="text-align:left" | Life – inv. contracts
| style="text-align:left" | USDm
| style="text-align:left" | Fee revenue
| style="text-align:left" | Fee revenue
| 717
| 717